IRUBIS
PrivateLast Round
Pre Seed
Aug 29, 2024
Total Funding Raised
$4.73M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
IRUBIS operates in Healthcare & Life Sciences and is based in Munich. Its latest recorded funding round was a Pre Seed round in August 2024.
IRUBIS is a biotechnology company that has developed a mid-infrared spectroscopy platform designed to monitor bioprocess parameters in real-time.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IRUBIS Comparables
Compare IRUBIS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nirrin Technologies | 88% | |
| CLADE | 82% | |
| GenSensor | 80% |
For institutional investors. Book with your work email.
IRUBIS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Aug 29, 2024 | ||||
| Seed | Oct 6, 2022 | ||||
| Convertible Debt | Mar 24, 2022 | ||||
| Grant | May 1, 2020 |
For institutional investors. Book with your work email.
IRUBIS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Verve Ventures | Pre Seed, Seed |
| Ventura BioMed Investors | Pre Seed, Seed |
| Initiative for Industrial Innovators | Seed |
| European Innovation Council Fund | Grant |
| High-Tech Gründerfonds | Pre Seed, Seed |
| BioProcess 360 Partners | Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 123% MoM to 1.3K.
- Jun 22, 2025
Added S Pact, a biotechnology startup, as a customer.
For institutional investors. Book with your work email.
IRUBIS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about IRUBIS's valuation, stock price, and market status.
Is IRUBIS a public or private company?
IRUBIS is a private company.
What is the current stock price of IRUBIS?
IRUBIS is a private company, so its shares have no public market price. Caplight tracks IRUBIS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is IRUBIS worth (valuation)?
Valuation information for IRUBIS is not publicly available.
Can I buy IRUBIS stock?
IRUBIS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was IRUBIS's last funding round?
IRUBIS's most recent funding round was Pre Seed on August 29, 2024.
Who are the main investors in IRUBIS?
Key investors in IRUBIS include Verve Ventures, Ventura BioMed Investors, High-Tech Gründerfonds, BioProcess 360 Partners.
Will IRUBIS IPO soon?
No public IPO plans have been announced for IRUBIS.
How can I track IRUBIS secondary market activity?
Caplight tracks bids, offers, and trades in IRUBIS's shares on secondary markets.